BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Kim SY, Choi DJ, Chung JW. Antibiotic treatment for Helicobacter pylori: Is the end coming? World J Gastrointest Pharmacol Ther 2015; 6(4): 183-198 [PMID: 26558152 DOI: 10.4292/wjgpt.v6.i4.183]
URL: https://www.wjgnet.com/1007-9327/full/v6/i4/183.htm
Number Citing Articles
Mansour Amin, Ali Akbar Shayesteh, Amirarsalan Serajian, Hamed Goodarzi. Assessment of Metronidazole and Clarithromycin Resistance Among Helicobacter pylori Isolates of Ahvaz (Southwest of Iran) During 2015 - 2016 by Phenotypic and Molecular MethodsJundishapur Journal of Microbiology 2019; (In Press) doi: 10.5812/jjm.80156
Sohaib Khan, Mohamed Sharaf, Ishfaq Ahmed, Tehsin Ullah Khan, Samah Shabana, Muhammad Arif, Syed Shabi Ul Hassan Kazmi, Chenguang Liu. Potential utility of nano-based treatment approaches to address the risk of Helicobacter pyloriExpert Review of Anti-infective Therapy 2022; 20(3): 407 doi: 10.1080/14787210.2022.1990041
Seokin Kang, Yuri Kim, Ji Yong Ahn, Hwoon-Yong Jung, Nayoung Kim, Hee Kyong Na, Jeong Hoon Lee, Kee Wook Jung, Do Hoon Kim, Kee Don Choi, Ho June Song, Gin Hyug Lee. Role of Antimicrobial Susceptibility Testing before First-Line Treatment Containing Clarithromycin for Helicobacter pylori Eradication in the Clinical SettingAntibiotics 2021; 10(2): 214 doi: 10.3390/antibiotics10020214
Elizabeth A. Marcus, George Sachs, David R. Scott. Eradication of Helicobacter pylori InfectionCurrent Gastroenterology Reports 2016; 18(7) doi: 10.1007/s11894-016-0509-x
Y. Dasteh Goli, R. Moniri. Efficacy of probiotics as an adjuvant agent in eradication ofHelicobacter pyloriinfection and associated side effectsBeneficial Microbes 2016; 7(4): 519 doi: 10.3920/BM2015.0130
Ali Chaudhry. Pharmacist guidelines and considerations for treating H. pyloriJournal of Analytical & Pharmaceutical Research 2018; 7(2) doi: 10.15406/japlr.2018.07.00222
Farnaz Fahimi, Mohammad Reza Tohidkia, Mehdi Fouladi, Reza Aghabeygi, Naser Samadi, Yadollah Omidi. Pleiotropic cytotoxicity of VacA toxin in host cells and its impact on immunotherapyBioImpacts 2017; 7(1): 59 doi: 10.15171/bi.2017.08
Skander Hathroubi, Julia Zerebinski, Karen M. Ottemann, Nancy E. Freitag, Regine Hengge, Timothy Cover. Helicobacter pylori Biofilm Involves a Multigene Stress-Biased Response, Including a Structural Role for FlagellamBio 2018; 9(5) doi: 10.1128/mBio.01973-18
Ryo Inose, Yuichi Muraki, Yoko Kamimoto, Yoshiki Kusama, Ryuji Koizumi, Daisuke Yamasaki, Masahiro Ishikane, Masaki Tanabe, Norio Ohmagari. The intended purpose and regional patterns of use of antibiotics for managing Clostridioides (Clostridium) difficile infections: An analysis of the National Database of Health Insurance Claims and Specific Health Checkups data of JapanJournal of Infection and Chemotherapy 2022; 28(2): 356 doi: 10.1016/j.jiac.2021.12.004
Ronak Nikbazm, Zahra Rahimi, Yousef Moradi, Meysam Alipour, Farzad Shidfar. The effect of cranberry supplementation on Helicobacter pylori eradication in H. pylori positive subjects: a systematic review and meta-analysis of randomised controlled trialsBritish Journal of Nutrition 2022; 128(6): 1090 doi: 10.1017/S0007114521004256
Marina R. Wylie, Ian H. Windham, Faith C. Blum, Hannah Wu, D. Scott Merrell. In vitro antibacterial activity of nimbolide against Helicobacter pyloriJournal of Ethnopharmacology 2022; 285: 114828 doi: 10.1016/j.jep.2021.114828
Jun-Won Chung, Su Young Kim, Hee Jung Park, Chang Su Chung, Hee Woo Lee, Sun Mi Lee, Inki Kim, Jhang Ho Pak, Gin Hyug Lee, Jin-Yong Jeong. In Vitro Activity of Diphenyleneiodonium toward Multidrug-Resistant Helicobacter pylori StrainsGut and Liver 2017; 11(5): 648 doi: 10.5009/gnl16503
Maria Pina Dore, Hong Lu, David Y Graham. Role of bismuth in improvingHelicobacter pylorieradication with triple therapyGut 2016; 65(5): 870 doi: 10.1136/gutjnl-2015-311019
Joyanta K. Modak, Yu C. Liu, Claudiu T. Supuran, Anna Roujeinikova. Structure–Activity Relationship for Sulfonamide Inhibition of Helicobacter pylori α-Carbonic AnhydraseJournal of Medicinal Chemistry 2016; 59(24): 11098 doi: 10.1021/acs.jmedchem.6b01333
Amin Talebi Bezmin Abadi. Helicobacter pylori treatment: New perspectives using current experienceJournal of Global Antimicrobial Resistance 2017; 8: 123 doi: 10.1016/j.jgar.2016.11.008
Michael G. Bruce, Dana Bruden, Deidra Newbrough, Debby A. Hurlburt, Thomas W. Hennessy, Julie M. Morris, Alisa L. Reasonover, Frank Sacco, Brian J. McMahon. The relationship between previous antimicrobial use, antimicrobial resistance and treatment outcome among Alaskans treated forHelicobacter pyloriinfectionGastroHep 2019;  doi: 10.1002/ygh2.352
Marius Zeeb, Tobias Kerrinnes, Luka Cicin-Sain, Carlos A. Guzman, Wolfram Puppe, Thomas F. Schulz, Annette Peters, Klaus Berger, Stefanie Castell, André Karch. Seropositivity for pathogens associated with chronic infections is a risk factor for all-cause mortality in the elderly: findings from the Memory and Morbidity in Augsburg Elderly (MEMO) StudyGeroScience 2020; 42(5): 1365 doi: 10.1007/s11357-020-00216-x
Meiliang Gong, Yingjie Han, Xuning Wang, Hongjin Tao, Fansen Meng, Baicun Hou, Benjamin B. Sun, Gangshi Wang. Effect of Temperature on Metronidazole Resistance in Helicobacter pyloriFrontiers in Microbiology 2021; 12 doi: 10.3389/fmicb.2021.681911
Axel Haverich, Erin Colleen Boyle. Atherosclerosis Pathogenesis and Microvascular Dysfunction2019; : 9 doi: 10.1007/978-3-030-20245-3_2
Romelia Pop, Alexandru-Flaviu Tăbăran, Andrei Paul Ungur, Andrada Negoescu, Cornel Cătoi. Helicobacter Pylori-Induced Gastric Infections: From Pathogenesis to Novel Therapeutic Approaches Using Silver NanoparticlesPharmaceutics 2022; 14(7): 1463 doi: 10.3390/pharmaceutics14071463
Amin Talebi Bezmin Abadi. Vaccine against <i>Helicobacter pylori</i>: Inevitable approachWorld Journal of Gastroenterology 2016; 22(11): 3150-3157 doi: 10.3748/wjg.v22.i11.3150
Federico Antoniciello, Davide Roncarati, Annamaria Zannoni, Elena Chiti, Vincenzo Scarlato, Federica Chiappori. Targeting the Essential Transcription Factor HP1043 of Helicobacter pylori: A Drug Repositioning StudyFrontiers in Molecular Biosciences 2022; 9 doi: 10.3389/fmolb.2022.887564
A. Reiprich, L. Skalden, A. Raab, N. Bolotina, C. Lang. Lactobacillus crispatus DSM25988 as novel bioactive agent to co-aggregate Streptococcus pyogenes and to exclude it by binding to human cellsBeneficial Microbes 2022; 13(1): 83 doi: 10.3920/BM2021.0103
Ángel Gabriel Salinas Ibáñez, Anabella L. Origone, Constanza S. Liggieri, Sonia E. Barberis, Alba E. Vega. Asclepain cI, a proteolytic enzyme from Asclepias curassavica L., a south American plant, against Helicobacter pyloriFrontiers in Microbiology 2022; 13 doi: 10.3389/fmicb.2022.961958
Doaa M. Al-Eraky, Omneya M. Helmy, Yasser M. Ragab, Zeinab Abdul-Khalek, Eman A. El-Seidi, Mohammed A. Ramadan. Prevalence of CagA and antimicrobial sensitivity of H. pylori isolates of patients with gastric cancer in EgyptInfectious Agents and Cancer 2018; 13(1) doi: 10.1186/s13027-018-0198-1
Farkhondeh Poursina, Jamshid Fagri, Nasrin Mirzaei, Hajieh Ghasemian Safaei. Overexpression of spoT gene in coccoid forms of clinical Helicobacter pylori isolatesFolia Microbiologica 2018; 63(4): 459 doi: 10.1007/s12223-017-0557-0
Ali Sadra, Hyuck-Se Kweon, Sung-Oh Huh, Jaeyoung Cho. Gastroprotective and gastric motility benefits of AD-lico/Healthy Gut™ Glycyrrhiza inflata extractAnimal Cells and Systems 2017; 21(4): 255 doi: 10.1080/19768354.2017.1357660
Qian Zhao, Wen-jia Wang, Shui-ping Zhou, Jing Su, He Sun, Jing-bo Zhai, Yun-hui Hu. Jinghua Weikang capsule for helicobacter pylori eradication: A systematic review and meta-analysis with trial sequential analysisFrontiers in Pharmacology 2022; 13 doi: 10.3389/fphar.2022.959184
Sho Suzuki, Takuji Gotoda, Chika Kusano, Kunio Iwatsuka, Mitsuhiko Moriyama. The Efficacy and Tolerability of a Triple Therapy Containing a Potassium-Competitive Acid Blocker Compared With a 7-Day PPI-Based Low-Dose Clarithromycin Triple TherapyAmerican Journal of Gastroenterology 2016; 111(7): 949 doi: 10.1038/ajg.2016.182
Logan T. Roberts, Peter P. Issa, Evan S. Sinnathamby, Mallory Granier, Holly Mayeux, Treniece N. Eubanks, Kevin Malone, Shahab Ahmadzadeh, Elyse M. Cornett, Sahar Shekoohi, Alan D. Kaye. Helicobacter Pylori: A Review of Current Treatment Options in Clinical PracticeLife 2022; 12(12): 2038 doi: 10.3390/life12122038
Amirarsalan Serajian. PCR-RFLP Detection of Point Mutations in 23sr RNA Gene Responsible for Clarithromycin Resistance in Helicobacter pylori Isolates of Ahvaz, IranInternational Journal of Molecular Biology 2017; 2(5) doi: 10.15406/ijmboa.2017.02.00038
Su Young Kim, Jun-Won Chung. Best Helicobacter pylori Eradication Strategy in the Era of Antibiotic ResistanceAntibiotics 2020; 9(8): 436 doi: 10.3390/antibiotics9080436
Ángel Gabriel Salinas Ibáñez, Diego Vallés, Mauricio Adaro, Sonia Barberis, Alba E. Vega. Antimicrobial Effect of a Proteolytic Enzyme From the Fruits of Solanum granuloso-leprosum (Dunal) Against Helicobacter pyloriFrontiers in Nutrition 2021; 8 doi: 10.3389/fnut.2021.699955
David R. Scott, George Sachs, Elizabeth A. Marcus. The role of acid inhibition in Helicobacter pylori eradicationF1000Research 2016; 5: 1747 doi: 10.12688/f1000research.8598.1
Patrícia C. Henriques, Lia M. Costa, Catarina L. Seabra, Bernardo Antunes, Ricardo Silva-Carvalho, Susana Junqueira-Neto, André F. Maia, Pedro Oliveira, Ana Magalhães, Celso A. Reis, Fátima Gartner, Eliette Touati, Joana Gomes, Paulo Costa, M. Cristina L. Martins, Inês C. Gonçalves. Orally administrated chitosan microspheres bind Helicobacter pylori and decrease gastric infection in miceActa Biomaterialia 2020; 114: 206 doi: 10.1016/j.actbio.2020.06.035
Hiroshi Matsumoto, Akiko Shiotani, Ryo Katsumata, Minoru Fujita, Rui Nakato, Takahisa Murao, Manabu Ishii, Tomoari Kamada, Ken Haruma, David Y. Graham. Helicobacter pylori Eradication with Proton Pump Inhibitors or Potassium-Competitive Acid Blockers: The Effect of Clarithromycin ResistanceDigestive Diseases and Sciences 2016; 61(11): 3215 doi: 10.1007/s10620-016-4305-0
Shoko Ono, Mototsugu Kato, Soichi Nakagawa, Katsuhiro Mabe, Naoya Sakamoto. Vonoprazan improves the efficacy ofHelicobacter pylorieradication therapy with a regimen consisting of clarithromycin and metronidazole in patients allergic to penicillinHelicobacter 2017; 22(3): e12374 doi: 10.1111/hel.12374
Kalyani Saha, Deotima Sarkar, Uzma Khan, Bipul Chandra Karmakar, Sangita Paul, Asish K. Mukhopadhyay, Shanta Dutta, Sushmita Bhattacharya. Capsaicin Inhibits Inflammation and Gastric Damage during H pylori Infection by Targeting NF-kB–miRNA AxisPathogens 2022; 11(6): 641 doi: 10.3390/pathogens11060641
Youn I Choi, Jun-Won Chung, Kyoung Oh Kim, Kwang An Kwon, Yoon Jae Kim, Jung Ho Kim, Ja Young Seo, Dong Kyun Park. Tailored eradication strategy <i>vs</i> concomitant therapy for <i>Helicobacter pylori</i> eradication treatment in Korean patientsWorld Journal of Gastroenterology 2021; 27(31): 5247-5258 doi: 10.3748/wjg.v27.i31.5247
Andrzej Czyrski. Analytical Methods for Determining Third and Fourth Generation Fluoroquinolones: A ReviewChromatographia 2017; 80(2): 181 doi: 10.1007/s10337-016-3224-8
Vanita Mulay, Dhanashri Satav, Austin Fernandez, Priyanka Pisalwar, Shadab Ahmed. Alternatives to Antibiotics2022; : 499 doi: 10.1007/978-981-19-1854-4_20
Tuncer Ozturk, Demet Sengul, Ilker Sengul. Helicobacter pylori and association between its positivity and anatomotopographic settlement in the stomach with the host age rangeAnnals of African Medicine 2021; 20(1): 1 doi: 10.4103/aam.aam_69_19
Alessia Savoldi, Elena Carrara, David Y. Graham, Michela Conti, Evelina Tacconelli. Prevalence of Antibiotic Resistance in Helicobacter pylori: A Systematic Review and Meta-analysis in World Health Organization RegionsGastroenterology 2018; 155(5): 1372 doi: 10.1053/j.gastro.2018.07.007
Steffanie S. Amadei, Vicente Notario. A Significant Question in Cancer Risk and Therapy: Are Antibiotics Positive or Negative Effectors? Current Answers and Possible AlternativesAntibiotics 2020; 9(9): 580 doi: 10.3390/antibiotics9090580
Manuel Palencia, Tulio A. Lerma, Viviana Garcés, Mayra A. Mora, Jina M. Martínez, Sixta L. Palencia. Eco-friendly Functional Polymers2021; : 433 doi: 10.1016/B978-0-12-821842-6.00006-3
Daphne Ang, Seok Hwee Koo, Yiong Huak Chan, Thean Yen Tan, Gaik Hong Soon, Chin Kimg Tan, Kenneth Weicong Lin, Jaydeesh‐Khanna Krishnasamy‐Balasubramanian, Yu Jun Wong, Rahul Kumar, Rajesh R, Yiyuan Tan, Peng‐Lan Jeannie Ong, Yi‐Lyn Jessica Tan, James Weiquan Li, Andrew Boon‐Eu Kwek, Tiing Leong Ang. Clinical trial: seven‐day vonoprazan‐ versus 14‐day proton pump inhibitor‐based triple therapy for first‐line Helicobacter pylori eradication Alimentary Pharmacology & Therapeutics 2022; 56(3): 436 doi: 10.1111/apt.17070
Mahdi Tarhini, Mohammad Fayyad-Kazan, Hussein Fayyad-Kazan, Mahmoud Mokbel, Mohammad Nasreddine, Bassam Badran, Ghada Kchour. First-line treatment of Helicobacter pylori in Lebanon: Comparison of bismuth-containing quadruple therapy versus 14-days sequential therapyMicrobial Pathogenesis 2018; 117: 23 doi: 10.1016/j.micpath.2018.02.010
Carla Palacios-Gorba, Raquel Pina, Miguel Tortajada-Girbés, Ana Jiménez-Belenguer, Érica Siguemoto, Maria Antonia Ferrús, Dolores Rodrigo, Maria Consuelo Pina-Pérez. Caenorhabditis elegans as an in vivo model to assess fucoidan bioactivity preventing Helicobacter pylori infectionFood & Function 2020; 11(5): 4525 doi: 10.1039/D0FO00768D
Huili Shen, Yijie Chen, Xiaohui Li, Jing Yan, Junjie Zhao, Demin Kong, Yanxia Shi, Zhihui Li, Jihong Wang, Na Shao, Zhenghui Wang, Xueliang Wu. Impact of Helicobacter pylori Infection and Outcome of Anti-Helicobacter pylori Therapy in Patients with Reflux LaryngopharyngitisEvidence-Based Complementary and Alternative Medicine 2022; 2022: 1 doi: 10.1155/2022/8266321